An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells

Blood

Volumn 96, Issue 10, 2000, Pages 3414-3421

  Rosler, E S ^a   Brandt, J E ^a   Chute, J ^a   Hoffman, R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE; BONE MARROW; BONE MARROW CELL; CELL KINETICS; CONTROLLED STUDY; FETUS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SWINE; UMBILICAL CORD BLOOD; VASCULAR ENDOTHELIUM;

EID: 0034670012     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3414     Document Type: Article

References (52)

1. Stem cells: Units of development, units of regeneration, and units in evolution
2. The biology of hematopoietic stem cells
3. Delineation of the human hematolymphoid system: Potential applications of defined cell populations in cellular therapy
4. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts
5. Ontogeny-related changes in proliferative potential of human hematopoietic cells
6. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells
7. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source
8. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential
9. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors
10. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts
11. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons
12. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function
13. Loss of stem cell repopulating ability upon transplantation: Effects of donor age, cell number, and transplantation procedure
14. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells
15. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit
16. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
17. Factors associated with outcome after cord blood transplantation in children with acute leukemia: Eurocord-Cord Blood Transplant Group
18. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor
19. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts
20. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
21. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
22. Outcome of cord-blood transplantation trom related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group
23. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
24. Retention and multilineage expression of human hematopoietic stem cells in human-sheep chimeras
25. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells
26. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults
27. Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines
28. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice
29. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo
30. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
31. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
32. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
33. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow
34. Competitive repopulation in unirradiated normal recipients
35. Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation
36. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts
37. Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: Models for human umbilical cord blood
38. Relative to adult marrow, fetal liver repopulates nearly five times more effectively tong-term than short-term
39. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells
40. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow
41. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: Requirement for cell-to-cell interactions and colony-stimulating factors
42. Bone marrow repopulating by human marrow stem cells following long-term expansion culture on a porcine-endothelial cell line
43. Cocultivation of umbilical cord blood cells with endothelial cells leads to external amplification of competent CD34+CD38- cells
44. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft
45. Implantation and maintenance of functional human bone marrow in SCID-hu mice
46. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood
47. Measurement of marrow repopulating potential of human hematopoietic progenitor and stem cells using a fetal sheep model
48. Immunodeficient mice as models of human hematopoietic stem cell engraftment
49. Engraftment and retroviral marking of CD34+ and CD34+CD38- human hematopoietic progenitors assessed in immune-deficient mice
50. The homing of hematopoietic stem cells to the bone marrow
51. Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo
52. Transplantation of unrelated cord blood cells